| 发明名称 |
ANTI-CD160 SPECIFIC ANTIBODIES FOR THE TREATMENT OF EYE DISORDERS BASED ON NEOANGIOGENESIS |
| 摘要 |
<p>The present invention relates to the use of at least one anti-CD 160 antibody, preferably a compound selected from CL1-R2 monoclonal antibody (which may be obtained by the hybridoma CNCM 1-3204), its conservative fragments and its conservative derivatives, for preparing a drug designed to treat neovascular eye diseases.</p> |
| 申请公布号 |
CA2796312(A1) |
申请公布日期 |
2011.12.01 |
| 申请号 |
CA20112796312 |
申请日期 |
2011.05.27 |
| 申请人 |
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);MABLIFE |
发明人 |
LE BOUTEILLER, PHILIPPE;BENSUSSAN, ARMAND |
| 分类号 |
A61K39/395;A61P27/02;C07K16/22;C07K16/28 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
